Novel Drug OK'd for Ulcerative Colitis

(MedPage Today) -- The FDA approved mirikizumab (Omvoh) for the treatment of adults with moderately to severely active ulcerative colitis, manufacturer Eli Lilly announced on Thursday. The injectable drug selectively binds the p19 subunit of interleukin...
Source: MedPage Today Public Health - Category: American Health Source Type: news